

Cover Story
Free
By Matthew Bin Han Ong
The White House moonshot to accelerate progress in cancer research directs FDA to consolidate its oncology portfolio.
In Brief


Funding Opportunities
Drugs & Targets


Trending Stories
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - NCAB asks for help from administration as NCI deals with deluge of grant applications
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Trump’s tariffs on generic drugs are “another wrinkle in an already unstable system”
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home
- Raja Flores says oncology is loose with staging jargon, and now “it’s confusing my patients.”











